First Look Analyst Calls Briefing for Monday, October 31, 2022
Here's a first look analysts' research calls for Monday morning.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> BioMarin Pharmaceutical (BMRN) upgraded to Outperform from Perform at Oppenheimer; tgt raised to $110
> Cullen/Frost (CFR) upgraded to In-line from Underperform at Evercore ISI; tgt raised to $160
Downgrades:
> ABB Ltd (ABB) downgraded to Buy from Conviction Buy at Goldman
> Advanced Micro (AMD) downgraded to Market Perform from Outperform at Northland Capital; tgt lowered to $60
> Ameris Bancorp (ABCB) downgraded to Mkt Perform from Outperform at Raymond James
> Aon (AON) downgraded to Underperform from Mkt Perform at Raymond James
Others:
> Ares Commercial Real Estate (ACRE) resumed with a Buy at BofA Securities; tgt $13
> Business First Bancshares (BFST) initiated with an Outperform at Raymond James; tgt $28
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.